Admission prevention in COPD: non-pharmacological management

Area of Science:

• Pulmonary Medicine
• Respiratory Health
• Clinical Management

Background:

• Exacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of hospitalization globally.
• These events significantly diminish patients' quality of life and strain healthcare resources.
• While pharmacotherapies aid prevention, substantial room exists for other interventions to manage exacerbations.

Purpose of the Study:

• To review the benefits and limitations of established non-pharmacological therapies for COPD exacerbation prevention.
• To explore emerging strategies and future directions in COPD management.
• To highlight interventions that can improve clinical outcomes and preserve patient quality of life.

Main Methods:

• Literature review of pulmonary rehabilitation, non-invasive ventilation, smoking cessation, and long-term oxygen therapy.
• Analysis of supported discharge, advanced care coordination, and telehealth programs.
• Synthesis of evidence on the impact of these therapies on exacerbation frequency and quality of life.

Main Results:

• Pulmonary rehabilitation, non-invasive ventilation, smoking cessation, and LTOT offer benefits but have limitations in preventing exacerbations.
• Supported discharge, care coordination, and telehealth show promise as future management strategies.
• These interventions collectively aim to reduce the burden of COPD exacerbations on patients and healthcare systems.

Conclusions:

• Non-pharmacological interventions are crucial for managing COPD exacerbations and improving patient outcomes.
• Integrating pulmonary rehabilitation, ventilation support, smoking cessation, and oxygen therapy is key.
• Future directions including supported discharge and telehealth offer new avenues for COPD care and exacerbation prevention.